Water Tower Podcast Recap: A Conversation with CEO Ben Lightburn
CEO and Co-Founder of Filament Health Ben Lightburn joined The Water Tower Hour podcast. The company is the first and currently the only exclusively natural psychedelic-derived drug developer, with the initial focus on ‘magic mushroom’ compounds, led by psilocybin and psilocin. Lightburn explains what brought him to the psychedelics space and the reasons behind the launch of Filament in 2020. Lightburn highlights what he believes sets Filament’s naturally-derived drug candidates apart from synthetically manufactured psychedelic compounds. Lightburn discusses the development status of the company’s lead natural psilocybin-based drug candidate PEX010, which targets substance abuse disorders, specifically methamphetamine and opioids. The podcast discusses the strategic and financial benefits of Filament’s IP-protected natural psychedelic compound technology out-licensing program and its expanding partnership network, which includes drug developers, research institutions, and government agencies. Lightburn explains the reasons Filament recently entered a definitive agreement to combine with SPAC Jupiter Acquisition Corp (NASDAQ: JAQC). Listen Here. You can listen to The Water Tower Hour on Apple Podcasts, Google Podcasts, Spotify, or our website.
Water Tower Research is built on the foundation of democratizing information flow. We bridge the growing information gap between companies and investors through our investor engagement strategies and open-access research platform.
Our research analysts are Wall Street veterans with the experience and knowledge to work with companies and investors in tandem. We provide access to the information and content that anchors the due diligence process for both professional money managers and individual investors. We leverage traditional research distribution channels and the best of modern digital strategies and tactics to amplify this information flow globally to engage all categories of investors and stakeholders.
Information flow is the foundation for creating investor awareness, knowledge, and engagement. Our mission is to help companies and investors have the tools they need and achieve their goals.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.